1. A SARS-CoV-2 nucleocapsid ELISA represents a low-cost alternative to lateral flow testing for community screening in LMI countries. Issue 1 (January 2022) Authors: Humbert, Maria Victoria; Opurum, Precious Chinonyerem; Brendish, Nathan J; Poole, Stephen; He, Peijun; Katis, Ioannis; Quaye, Jerry; Bediako, Yaw; Duriez, Patrick Jacques; Eason, Robert W; Sones, Collin; Quaye, Osbourne; Awandare, Gordon A; Christodoulides, Myron; Clark, Tristan W; Quashie, Peter... Journal: Journal of infection Issue: Volume 84:Issue 1(2022) Page Start: 48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗